Screener
Veradermics MANE Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Veradermics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 5:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001827635-26-000019
| (in thousands, except share and per share amounts) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net loss | $(27,232) | $(12,400) |
| Net loss attributable to common stock | $(30,011) | $(14,582) |
| Net loss per share of common stock, basic and diluted | $(1.32) | $(19.79) |
| Weighted average common stock outstanding, basic and diluted | 22,704,124 | 736,933 |
| Other comprehensive loss: | ||
| Net unrealized losses on marketable securities | (584) | — |
| Total other comprehensive loss | (584) | — |
| Total comprehensive loss | $(27,816) | $(12,400) |
Item 1. Condensed Consolidated Financial Statements (
FAQ
- What is Veradermics's comprehensive income (loss), net of tax, attributable to parent?
- Veradermics (MANE) reported comprehensive income (loss), net of tax, attributable to parent of -$27.82M in Q1 2026.
- How has Veradermics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Veradermics's comprehensive income (loss), net of tax, attributable to parent decreased by 124.3% year-over-year, from -$12.4M to -$27.82M.
Ask your AI about Veradermics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude